Bolno Paul's Form 4 filing
Wave Life Sciences, Inc. (WVE) · filed Aug 26, 2025
- Accession no.
- 0000950170-25-111567
- Filed
- Aug 26, 2025
- Trade date
- Aug 22, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $2.20M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bolno PaulCIK 0001657710 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 22, 2025 | Ordinary Shares | SSaleDisposed | −217,351 | $10.10 | −$2,195,245.1 | 121,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.